{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:28:42Z","timestamp":1790605722217,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL-139521"],"award-info":[{"award-number":["R01 HL-139521"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-155091"],"award-info":[{"award-number":["HL-155091"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10-OD019941"],"award-info":[{"award-number":["1S10-OD019941"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The potential of nanoparticles as effective drug delivery tools for treating failing hearts in heart failure remains a challenge. Leveraging the rapid infiltration of neutrophils into infarcted hearts after myocardial infarction (MI), we developed a nanoparticle platform engineered with neutrophil membrane proteins for the targeted delivery of TAPI-1, a TACE\/ADAM17 inhibitor, to the inflamed myocardium, aiming to treat cardiac dysfunction and remodelling in rats with MI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Neutrophil-mimic liposomal nanoparticles (Neu-LNPs) were constructed by integrating synthesized liposomal nanoparticles with LPS-stimulated neutrophil membrane fragments and then loaded with TAPI-1. MI rats were treated with TAPI-1 delivered via Neu-LNPs for 4 weeks. Left ventricular function was assessed by echocardiography and cardiac fibrosis was evaluated post-treatment. The novel Neu-LNPs maintained typical nanoparticle features, but with increased biocompatibility. Neu-LNPs demonstrated improved targeting ability and cellular internalization, facilitated by LFA1\/Mac1\/ICAM-1 interaction. Neu-LNPs displayed higher accumulation and cellular uptake by macrophages and cardiomyocytes in infarcted hearts post-MI, with a sustained duration. Treatments with TAPI-1-Neu-LNPs demonstrated greater protection against myocardial injury and cardiac dysfunction in MI rats compared to untargeted TAPI-1, along with reduced cardiac collagen deposition and expression of fibrosis biomarkers as well as altered immune cell compositions within the hearts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Targeted treatment with TACE\/ADAM17 inhibitor delivered via biomimetic nanoparticles exhibited pronounced advantages in improving left ventricle function, mitigating cardiac remodelling, and reducing inflammatory responses within the infarcted hearts. This study underscores the effectiveness of Neu-LNPs as a drug delivery strategy to enhance therapeutic efficacy in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cvr\/cvaf039","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:30:40Z","timestamp":1741105840000},"page":"760-774","source":"Crossref","is-referenced-by-count":15,"title":["Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling"],"prefix":"10.1093","volume":"121","author":[{"given":"Qing","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Carver College of Medicine , 200 Hawkins Drive, Iowa City, IA 52242 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Carver College of Medicine , 200 Hawkins Drive, Iowa City, IA 52242 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Carver College of Medicine , 200 Hawkins Drive, Iowa City, IA 52242 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Carver College of Medicine , 200 Hawkins Drive, Iowa City, IA 52242 ,","place":["USA"]},{"name":"Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine , 501 Newton Road, Iowa City, IA 52242 ,","place":["USA"]},{"name":"Veteran Affairs Medical Center , Research and Development, 601 HWY 6 WEST, Iowa City, IA 52246 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-4059","authenticated-orcid":false,"given":"Shun-Guang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa Carver College of Medicine , 200 Hawkins Drive, Iowa City, IA 52242 ,","place":["USA"]},{"name":"Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine , 501 Newton Road, Iowa City, IA 52242 ,","place":["USA"]},{"name":"Veteran Affairs Medical Center , Research and Development, 601 HWY 6 WEST, Iowa City, IA 52246 ,","place":["USA"]},{"name":"Iowa Neuroscience Institute, University of Iowa , 169 Newton Road, Iowa City, IA 52242, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"2025052311271650700_cvaf039-B1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/joim.13254","article-title":"Nanotechnology for modern medicine: next step towards clinical translation","volume":"290","author":"Sindhwani","year":"2021","journal-title":"J Intern Med"},{"key":"2025052311271650700_cvaf039-B2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/molecules25010112","article-title":"The history of nanoscience and nanotechnology: from chemical\u2013physical applications to nanomedicine","volume":"25","author":"Bayda","year":"2019","journal-title":"Molecules"},{"key":"2025052311271650700_cvaf039-B3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2025052311271650700_cvaf039-B4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejps.2012.12.006","article-title":"A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics","volume":"48","author":"Steichen","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"2025052311271650700_cvaf039-B5","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/ja2084338","article-title":"Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake","volume":"134","author":"Walkey","year":"2012","journal-title":"J Am Chem Soc"},{"key":"2025052311271650700_cvaf039-B6","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"2025052311271650700_cvaf039-B7","first-page":"879","article-title":"Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy","volume":"3","author":"Yaman","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"2025052311271650700_cvaf039-B8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J Control Release"},{"key":"2025052311271650700_cvaf039-B9","doi-asserted-by":"crossref","first-page":"e1706759","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv Mater"},{"key":"2025052311271650700_cvaf039-B10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-biophys-070816-033620","article-title":"Nanodiscs: a controlled bilayer surface for the study of membrane proteins","volume":"47","author":"McLean","year":"2018","journal-title":"Annu Rev Biophys"},{"key":"2025052311271650700_cvaf039-B11","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2217\/nnm-2017-0225","article-title":"Cell membrane coated nanoparticles: next-generation therapeutics","volume":"12","author":"Narain","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"2025052311271650700_cvaf039-B12","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.3390\/molecules26113428","article-title":"Recent advances of cell membrane coated nanoparticles in treating cardiovascular disorders","volume":"26","author":"Zhu","year":"2021","journal-title":"Molecules"},{"key":"2025052311271650700_cvaf039-B13","doi-asserted-by":"crossref","first-page":"e81157","DOI":"10.1371\/journal.pone.0081157","article-title":"A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors","volume":"8","author":"Stapleton","year":"2013","journal-title":"PLoS One"},{"key":"2025052311271650700_cvaf039-B14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"2025052311271650700_cvaf039-B15","first-page":"457","article-title":"The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair","volume":"41","author":"Butterfield","year":"2006","journal-title":"J Athl Train"},{"key":"2025052311271650700_cvaf039-B16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"2025052311271650700_cvaf039-B17","doi-asserted-by":"crossref","first-page":"1052304","DOI":"10.3389\/fphys.2022.1052304","article-title":"Reducing brain TACE activity improves neuroinflammation and cardiac function in heart failure rats","volume":"13","author":"Yu","year":"2022","journal-title":"Front Physiol"},{"key":"2025052311271650700_cvaf039-B18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/HYPERTENSIONAHA.119.12651","article-title":"Brain TACE (tumor necrosis factor-alpha-converting enzyme) contributes to sympathetic excitation in heart failure rats","volume":"74","author":"Yu","year":"2019","journal-title":"Hypertension"},{"key":"2025052311271650700_cvaf039-B19","doi-asserted-by":"crossref","first-page":"1032434","DOI":"10.3389\/fnins.2022.1032434","article-title":"Brain interleukin-17A contributes to neuroinflammation and cardiac dysfunction in rats with myocardial infarction","volume":"16","author":"Yu","year":"2022","journal-title":"Front Neurosci"},{"key":"2025052311271650700_cvaf039-B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2021.12.030","article-title":"Transforming growth factor-alpha acts in hypothalamic paraventricular nucleus to upregulate ERK1\/2 signaling and expression of sympathoexcitatory mediators in heart failure rats","volume":"483","author":"Yu","year":"2022","journal-title":"Neuroscience"},{"key":"2025052311271650700_cvaf039-B21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"2025052311271650700_cvaf039-B22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6591-5_2","volume-title":"Liposomes: Methods and Protocols","author":"Zhang","year":"2017"},{"key":"2025052311271650700_cvaf039-B23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s00580-013-1808-3","article-title":"Comparison of four methods for the isolation of murine blood neutrophils with respect to the release of reactive oxygen and nitrogen species and the expression of immunological receptors","volume":"23","author":"Marchi","year":"2014","journal-title":"Comp Clin Path"},{"key":"2025052311271650700_cvaf039-B24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nmat4644","article-title":"Biomimetic proteolipid vesicles for targeting inflamed tissues","volume":"15","author":"Molinaro","year":"2016","journal-title":"Nat Mater"},{"key":"2025052311271650700_cvaf039-B25","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.bbagen.2014.07.003","article-title":"A Fourier transform infrared spectroscopy study of cell membrane domain modifications induced by docosahexaenoic acid","volume":"1840","author":"Mereghetti","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014General Subjects"},{"key":"2025052311271650700_cvaf039-B26","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.99.11.1492","article-title":"Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium","volume":"99","author":"Irwin","year":"1999","journal-title":"Circulation"},{"key":"2025052311271650700_cvaf039-B27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yjmcc.2009.12.013","article-title":"Tumor necrosis factor-alpha produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload","volume":"49","author":"Chen","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2025052311271650700_cvaf039-B28","doi-asserted-by":"crossref","first-page":"151887","DOI":"10.1016\/j.imbio.2019.11.022","article-title":"Potential anti-arthritic and anti-inflammatory effects of TNF-alpha processing inhibitor-1 (TAPI-1): a new approach to the treatment of S. aureus arthritis","volume":"225","author":"Sultana","year":"2020","journal-title":"Immunobiology"},{"key":"2025052311271650700_cvaf039-B29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00001573-199905000-00003","article-title":"An overview of tumor necrosis factor alpha and the failing human heart","volume":"14","author":"Torre-Amione","year":"1999","journal-title":"Curr Opin Cardiol"},{"key":"2025052311271650700_cvaf039-B30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0735-1097(99)00600-2","article-title":"The role of tumor necrosis factor in the pathophysiology of heart failure","volume":"35","author":"Feldman","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025052311271650700_cvaf039-B31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1054\/jcaf.2002.130237","article-title":"Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific","volume":"8","author":"Krum","year":"2002","journal-title":"J Card Fail"},{"key":"2025052311271650700_cvaf039-B32","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"2025052311271650700_cvaf039-B33","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"2025052311271650700_cvaf039-B34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2302\/kjm.2012-0003-RE","article-title":"A brief history of tumor necrosis factor alpha-converting enzyme: an overview of ectodomain shedding","volume":"62","author":"Horiuchi","year":"2013","journal-title":"Keio J Med"},{"key":"2025052311271650700_cvaf039-B35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/370555a0","article-title":"Processing of tumour necrosis factor-alpha precursor by metalloproteinases","volume":"370","author":"Gearing","year":"1994","journal-title":"Nature"},{"key":"2025052311271650700_cvaf039-B36","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.108.846105","article-title":"Tumor necrosis factor-alpha and its receptors 1 and 2: yin and yang in myocardial infarction?","volume":"119","author":"Schulz","year":"2009","journal-title":"Circulation"},{"key":"2025052311271650700_cvaf039-B37","doi-asserted-by":"crossref","first-page":"H743","DOI":"10.1152\/ajpheart.00166.2007","article-title":"Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction","volume":"293","author":"Monden","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025052311271650700_cvaf039-B38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"2025052311271650700_cvaf039-B39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41423-020-0412-0","article-title":"Neutrophil chemoattractant receptors in health and disease: double-edged swords","volume":"17","author":"Metzemaekers","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2025052311271650700_cvaf039-B40","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.2147\/IJN.S328705","article-title":"The advances of neutrophil-derived effective drug delivery systems: a key review of managing tumors and inflammation","volume":"16","author":"Wang","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"2025052311271650700_cvaf039-B41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nri.2016.49","article-title":"Neutrophil migration in infection and wound repair: going forward in reverse","volume":"16","author":"de Oliveira","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2025052311271650700_cvaf039-B42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1091\/mbc.E16-12-0827","article-title":"Ligand-specific binding forces of LFA-1 and Mac-1 in neutrophil adhesion and crawling","volume":"29","author":"Li","year":"2018","journal-title":"Mol Biol Cell"},{"key":"2025052311271650700_cvaf039-B43","first-page":"161","article-title":"Leukocyte CD11\/CD18 integrins: biological and clinical relevance","volume":"80","author":"Mazzone","year":"1995","journal-title":"Haematologica"},{"key":"2025052311271650700_cvaf039-B44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0008-6363(98)00236-3","article-title":"Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction","volume":"41","author":"Niessen","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2025052311271650700_cvaf039-B45","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"Sousa de Almeida","year":"2021","journal-title":"Chem Soc Rev"},{"key":"2025052311271650700_cvaf039-B46","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.2147\/IJN.S203330","article-title":"Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells","volume":"14","author":"Lujan","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"2025052311271650700_cvaf039-B47","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/CS20040229","article-title":"Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction","volume":"108","author":"Shimoda","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"2025052311271650700_cvaf039-B48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/CS20020367","article-title":"Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction","volume":"105","author":"Akatsu","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"2025052311271650700_cvaf039-B49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"2025052311271650700_cvaf039-B50","doi-asserted-by":"crossref","first-page":"2374289520976639","DOI":"10.1177\/2374289520976639","article-title":"Educational case: myocardial infarction: histopathology and timing of changes","volume":"7","author":"Ghafoor","year":"2020","journal-title":"Acad Pathol"},{"key":"2025052311271650700_cvaf039-B51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00019501-199502000-00010","article-title":"Sequential changes in the distribution of type I and III collagens in the infarct zone: immunohistochemical study of experimental myocardial infarction in the rat","volume":"6","author":"Inoue","year":"1995","journal-title":"Coron Artery Dis"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaf039\/62272566\/cvaf039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/5\/760\/62272566\/cvaf039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/5\/760\/62272566\/cvaf039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:27:41Z","timestamp":1747999661000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/5\/760\/8052077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3,5]]},"published-print":{"date-parts":[[2025,5,23]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaf039","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,5]]}}}